Epstein-Barr virus genes and cancer cells
- 1 January 1997
- journal article
- review article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 51 (6-7) , 258-267
- https://doi.org/10.1016/s0753-3322(97)83541-x
Abstract
No abstract availableKeywords
This publication has 56 references indexed in Scilit:
- A strategy for specific targeting of therapeutic agents to tumour cells of virus-associated cancersGene Therapy, 1997
- Epstein–Barr virus–driven gene therapy for EBV–related lymphomasNature Medicine, 1996
- Truncated Mammalian Notch1 Activates CBF1/RBPJk-Repressed Genes by a Mechanism Resembling That of Epstein-Barr Virus EBNA2Molecular and Cellular Biology, 1996
- Mediation of Epstein-Barr Virus EBNA2 Transactivation by Recombination Signal-Binding Protein J κScience, 1994
- Binding and Suppression of the Myc Transcriptional Activation Domain by p107Science, 1994
- Epstein-Barr virus and Hodgkin's disease: transcriptional analysis of virus latency in the malignant cells.The Journal of Experimental Medicine, 1993
- Transcription of BamHI-A region of the EBV genome in NPC tissues and B cellsVirology, 1992
- Loss of heterozygosity on the short arm of chromosome 3 in nasopharyngeal carcinomaCancer Genetics and Cytogenetics, 1991
- Epstein-Barr virus in nasal T-cell lymphomas in patients with lethal midline granulomaThe Lancet, 1990
- Expression of Epstein‐Barr virus‐encoded proteins in nasopharyngeal carcinomaInternational Journal of Cancer, 1988